These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1676680)
1. Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists. Speiser Z; Gordon I; Rehavi M; Gitter S Eur J Pharmacol; 1991 Mar; 195(1):75-83. PubMed ID: 1676680 [TBL] [Abstract][Full Text] [Related]
2. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade. McDevitt DG; Brown HC; Carruthers SG; Shanks RG Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753 [TBL] [Abstract][Full Text] [Related]
3. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Miwa S; Muramatsu I Life Sci; 2007 Jul; 81(5):399-404. PubMed ID: 17628611 [TBL] [Abstract][Full Text] [Related]
4. Time course and extent of alpha 1-adrenoceptor density changes in rat heart after beta-adrenoceptor blockade. Steinkraus V; Nose M; Scholz H; Thormählen K Br J Pharmacol; 1989 Feb; 96(2):441-9. PubMed ID: 2564293 [TBL] [Abstract][Full Text] [Related]
5. Exercise-induced hand tremor: a possible test for beta 2-adrenoceptor selectivity in man? Abila B; Wilson JF; Marshall RW; Richens A Br J Clin Pharmacol; 1986 Jul; 22(1):104-7. PubMed ID: 2874824 [TBL] [Abstract][Full Text] [Related]
6. Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment. Michel MC; Pingsmann A; Beckeringh JJ; Zerkowski HR; Doetsch N; Brodde OE Br J Pharmacol; 1988 Jul; 94(3):685-92. PubMed ID: 2902891 [TBL] [Abstract][Full Text] [Related]
7. Developmental changes in rat brain monoamine metabolism and beta-adrenoceptor subtypes after chronic prenatal exposure to propranolol. Erdtsieck-Ernste EB; Feenstra MG; Botterblom MH; Boer GJ Neurochem Int; 1993 Jun; 22(6):589-98. PubMed ID: 8390323 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of physiological finger tremor by intravenous isoprenaline infusions in man: evaluation of its role in the assessment of beta-adrenoceptor antagonists. Arnold JM; McDevitt DG Br J Clin Pharmacol; 1984 Aug; 18(2):145-52. PubMed ID: 6148957 [TBL] [Abstract][Full Text] [Related]
9. Effect of propranolol treatment in pregnant rats on motor activity and avoidance learning of the offspring. Speiser Z; Shved A; Gitter S Psychopharmacology (Berl); 1983; 79(2-3):148-54. PubMed ID: 6405421 [TBL] [Abstract][Full Text] [Related]
10. The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats. Day MD; Roach AG Clin Sci Mol Med Suppl; 1975 Jun; 2():269s-272s. PubMed ID: 28878 [TBL] [Abstract][Full Text] [Related]
11. The effects of (+/-)-, (+)-, and (-)-atenolol, sotalol, and amosulalol on the rat left atria and portal vein. Doggrell SA Chirality; 1993; 5(1):8-14. PubMed ID: 8095397 [TBL] [Abstract][Full Text] [Related]
12. A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism. Funck-Brentano C; Silberstein DJ; Roden DM; Wood AJ; Woosley RL Br J Clin Pharmacol; 1990 Aug; 30(2):195-202. PubMed ID: 2169833 [TBL] [Abstract][Full Text] [Related]
13. beta-1 and beta-2, but not alpha-1 and alpha-2, adrenoceptor blockade delays rat cutaneous wound healing. Romana-Souza B; Santos JS; Monte-Alto-Costa A Wound Repair Regen; 2009; 17(2):230-9. PubMed ID: 19320892 [TBL] [Abstract][Full Text] [Related]
14. Beta-adrenoceptor antagonism and the hyperthyroid rat heart. Amos G; Kerr D; Sernia C; Brown L J Cardiovasc Pharmacol; 1994 Aug; 24(2):336-43. PubMed ID: 7526070 [TBL] [Abstract][Full Text] [Related]
15. Effects of propranolol and atenolol on immobilization stress-induced hypertension and down-regulation of central beta-adrenoceptors in rats. Takita M; Oda Y; Kigoshi S; Muramatsu I Pharmacol Biochem Behav; 1995 Feb; 50(2):225-32. PubMed ID: 7740061 [TBL] [Abstract][Full Text] [Related]
16. Chronic beta-adrenoceptor antagonist treatment modulates human cardiac and vascular beta-adrenoceptor density in a subtype-selective fashion. Brodde OE; Michel MC; Wang XL; Zerkowski HR J Hypertens Suppl; 1988 Dec; 6(4):S497-500. PubMed ID: 2907348 [TBL] [Abstract][Full Text] [Related]
17. Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog. Allely MC; Ungar A Br J Pharmacol; 1985 Oct; 86(2):393-8. PubMed ID: 2864972 [TBL] [Abstract][Full Text] [Related]
18. Chronic β-adrenoceptor antagonists upregulate the rat alveolar macrophage adrenergic system through the β1-subtype. Guo YP; Liu Y; Li JB; Huang Y; Qi HP; Xie J; Cui XG; Yue ZY; Li WZ Cell Physiol Biochem; 2011; 28(2):315-22. PubMed ID: 21865739 [TBL] [Abstract][Full Text] [Related]
20. Reduction by beta-adrenoceptor blockade of hypoxia-induced right heart hypertrophy in the rat. Ostman-Smith I Br J Pharmacol; 1995 Nov; 116(6):2698-702. PubMed ID: 8590992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]